A new study of more than 111,000 women ages 45 to 80 found those on GLP-1 medications had a reduced risk of developing breast ...

Amgen is developing monthly GLP-1 injections aimed at improving convenience and long-term adherence for patients.

A new study found that GLP-1 drugs lowered the risk of breast cancer by about 30%. The effect may be related to the metabolic ...

The story of GLP-1 drugs keeps getting bigger. First they transformed the treatment of diabetes. Then they upended the ...

GLP-1 drugs may be linked to a lower risk of cancer progression, according to new research that will be presented next week ...

A growing body of evidence suggests that popular GLP-1 drugs, widely used for weight loss and diabetes, can provide ...

A Penn Medicine study found that women taking GLP‑1 drugs such as Wegovy had a slightly lower rate of breast cancer diagnoses ...

Among adults with both obesity and an autoimmune disease, those taking a glucagon-like peptide-receptor 1 agonist (GLP-1RA) ...

Among adults with both obesity and an autoimmune disease, those taking a glucagon-like peptide-receptor 1 agonist (GLP-1RA) ...

Extra weight can stress the knees, leading to pain and a higher risk of knee replacement surgery. Adults who took a GLP-1 ...